Getting the body to make its own cancer drugs
Imagine that we could instruct our bodies to make the drugs they need themselves. The gene technology that makes this possible is called mRNA therapy, which may become a major tool in the treatment of multiple diseases. Norwegian researchers are currently helping to develop a drug of this kind to treat the most aggressive form of breast cancer.
EU-OPENSCREEN ERIC: EU initiative supports research on future medical chemistry
Use EU-OPENSCREEN ERIC’s newly funded EU-OPENSCREEN-DRIVE project to advance your research now.
Experiments show that an “unknown” enzyme fights inflammation
An enzyme that normally repairs damaged DNA may be the key to a new treatment for inflammatory diseases.
Hoping to treat osteoarthritis using artificial cartilage tissue
A Norwegian-Swiss research team has succeeded in growing cartilage tissue cells using algae. Moreover, the new cells can reduce joint inflammation. This news gives hope for people suffering from arthrosis, also known as osteoarthritis.
New allergy test promises safer antibiotic use
Allergies to antibiotics are the commonest form of medication allergies and, in the worst cases, can result in anaphylaxis and death. SINTEF is participating in the development of a new allergy test that will make it easier to provide patients with safe and correct treatments.
Commercialising gas bubbles for cancer drug delivery
Researchers are now working to design stable micro-bubbles which, combined with ultrasound, can deliver cancer drugs straight to the target tumour.
Risk-takers are smarter
Do you often take chances and yet still land on your feet? Then you probably have a well-developed brain.
Towards a bioeconomic future
Can our forests, seaweed, grass and fisheries waste be transformed into new and valuable raw materials? Researchers are asking 1500 Norwegian companies what they're currently doing with their resources, and what they see themselves doing in 2030.